Shareholding disclosure

NeoMed Innovation IV Limited

Declared position

Threshold

Fell below threshold

Timeline

Published

15.11.2008

Transaction

06.11.2008

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA8BD00073

Beneficial owner

NeoMed Innovation IV Limited

Declared address

NeoMed Innovation IV Limited, St Helier, Jersey, JE4 5UT

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

NeoMed Innovation IV Limited

Santhera Pharmaceuticals Holding AG15.11.2008TA8BD00073

Disclosure summary

NeoMed Innovation IV Limited disclosed a holding in Santhera Pharmaceuticals Holding AG that fell below the publication threshold, published by SIX Exchange Regulation on 15.11.2008, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

NeoMed Innovation IV Limited disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 15.11.2008.

Publication date15.11.2008

Transaction date06.11.2008

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerNeoMed Innovation IV Limited

Declared addressNeoMed Innovation IV Limited, St Helier, Jersey, JE4 5UT

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTA8BD00073

Source: SIX Exchange Regulation · Publication date: 15.11.2008

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open